Karla A. Henning

2.6k total citations · 1 hit paper
23 papers, 1.9k citations indexed

About

Karla A. Henning is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Karla A. Henning has authored 23 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Oncology. Recurrent topics in Karla A. Henning's work include DNA Repair Mechanisms (7 papers), CRISPR and Genetic Engineering (7 papers) and Chemokine receptors and signaling (3 papers). Karla A. Henning is often cited by papers focused on DNA Repair Mechanisms (7 papers), CRISPR and Genetic Engineering (7 papers) and Chemokine receptors and signaling (3 papers). Karla A. Henning collaborates with scholars based in United States, Australia and Germany. Karla A. Henning's co-authors include Alan J. Korman, M. S. Srinivasan, M. J. Selby, Michael Quigley, John Engelhardt, Tseng-hui Timothy Chen, E C Friedberg, Ruth Halaban, Stephen L. Warren and David B. Bregman and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Karla A. Henning

21 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells

2013 670 citations M. J. Selby, John Engelhardt et al. Cancer Immunology Research profile →

Peers

Karla A. Henning

ONCOL

IMMUN

GENET

HEMAT

Catherine T. Yan United States

Anna Morena D’Alise Italy

Cristian Boboilă United States

David Satijn Netherlands

Trisha Norton Tanzania

Daniel J. Bolland United Kingdom

Elke Raderschall United States

Michela Di Virgilio Germany

Geulah Livshits United States

Susanne Edelhoff United States

Catherine T. Yan United States

Karla A. Henning

1.8k ×1.8

669 ×0.8

ONCOL

579 ×0.8

IMMUN

128 ×0.6

GENET

61 ×0.4

HEMAT

Citations per year, relative to Karla A. Henning Karla A. Henning (= 1×) peers Catherine T. Yan

Countries citing papers authored by Karla A. Henning

Since Specialization

Citations

This map shows the geographic impact of Karla A. Henning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karla A. Henning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karla A. Henning more than expected).

Fields of papers citing papers by Karla A. Henning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karla A. Henning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karla A. Henning. The network helps show where Karla A. Henning may publish in the future.

Co-authorship network of co-authors of Karla A. Henning

This figure shows the co-authorship network connecting the top 25 collaborators of Karla A. Henning. A scholar is included among the top collaborators of Karla A. Henning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karla A. Henning. Karla A. Henning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kenkel, Justin A., Po Y. Ho, Jason Ptacek, et al.. (2023). Abstract 2964: Targeting tumor-associated macrophages to enhance anti-tumor immunity with the Dectin-2 agonistic antibody BDC-3042. Cancer Research. 83(7_Supplement). 2964–2964. 1 indexed citations

Kenkel, Justin A., Po Y. Ho, Sameera Kongara, et al.. (2021). 862 Dectin-2, a novel target for tumor macrophage reprogramming in cancer immunotherapy. Regular and Young Investigator Award Abstracts. A903–A903.

Ackerman, Shelley E., Felix J. Hartmann, Cecelia I. Pearson, et al.. (2020). 603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration. SHILAP Revista de lepidopterología. A360.1–A360. 1 indexed citations

Bezman, Natalie, Ty Brender, Mark Maurer, et al.. (2017). PD-1 blockade enhances elotuzumab efficacy in mouse tumor models. Blood Advances. 1(12). 753–765. 42 indexed citations

Pazina, Tatiana, Ashley M. James, Alexander W. Macfarlane, et al.. (2017). The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and –independent mechanisms. OncoImmunology. 6(9). e1339853–e1339853. 64 indexed citations

Selby, M. J., John Engelhardt, Michael Quigley, et al.. (2013). Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells. Cancer Immunology Research. 1(1). 32–42. 670 indexed citations breakdown →

Korman, Alan J., John Engelhardt, Vafa Shahabi, et al.. (2013). Role of the immunoglobulin constant region in the antitumor activity of antibodies to cytotoxic T-lymphocyte antigen-4 (CTLA-4).. Journal of Clinical Oncology. 31(15_suppl). 9055–9055. 3 indexed citations

Kuhne, Michelle, Chin Pan, Fei Cao, et al.. (2012). BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic Malignancies. Clinical Cancer Research. 19(2). 357–366. 181 indexed citations

Kuhne, Michelle, Chin Pan, Karla A. Henning, et al.. (2009). Abstract #LB-150: A fully human anti-CXCR4 antibody induces apoptosis in vitro and shows anti tumor activity in vivo.. Cancer Research. 69. 1 indexed citations

10.

Reik, Andreas, Yuanyue Zhou, Trevor N. Collingwood, et al.. (2006). Enhanced protein production by engineered zinc finger proteins. Biotechnology and Bioengineering. 97(5). 1180–1189. 16 indexed citations

11.

Henning, Karla A., et al.. (1998). Humanizing the yeast telomerase template. Proceedings of the National Academy of Sciences. 95(10). 5667–5671. 41 indexed citations

12.

Bregman, David B., Ruth Halaban, Alain J. van Gool, et al.. (1996). UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells.. Proceedings of the National Academy of Sciences. 93(21). 11586–11590. 262 indexed citations

13.

Henning, Karla A., Lei Li, Narayan V. Iyer, et al.. (1995). The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell. 82(4). 555–564. 388 indexed citations

14.

Henning, Karla A., Carolyn A. Peterson, Randy J. Legerski, & Errol C. Friedberg. (1994). Cloning theDrosophilahomolog of the xeroderma pigmentosum complementation group C gene reveals homology between the predicted human andDrosophilapolypeptides and that encoded by the yeastRAD4gene. Nucleic Acids Research. 22(3). 257–261. 24 indexed citations

15.

Friedberg, E C & Karla A. Henning. (1993). The conundrum of xeroderma pigmentosum — A rare disease with frequent complexities. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 289(1). 47–53. 13 indexed citations

16.

Henning, Karla A., E C Friedberg, & Kenneth W. Adolph. (1993). Techniques and applications of microcell-mediated chromosome transfer to mammalian cells.. 134–150. 1 indexed citations

17.

Friedberg, Errol C., Karla A. Henning, Paul J. Saxon, et al.. (1990). Microcell-Mediated Chromosome Transfer: A Strategy for Studying the Genetics and Molecular Pathology of Human Hereditary Diseases with Abnormal Responses to DNA Damage. PubMed. 52. 257–267. 5 indexed citations

18.

Henning, Karla A., Roger A. Schultz, Gurbax S. Sekhon, & Errol C. Friedberg. (1990). Gene complementing xeroderma pigmentosum group A cells maps to distal human chromosome 9q. Somatic Cell and Molecular Genetics. 16(4). 395–400. 10 indexed citations

19.

Thompson, Larry H., Kerry W. Brookman, J.L. Minkler, et al.. (1985). DNA-Mediated Transfer of a Human DNA Repair Gene That Controls Sister Chromatid Exchange. Molecular and Cellular Biology. 5(4). 881–884. 9 indexed citations

20.

Thompson, Larry H., Kerry W. Brookman, J.L. Minkler, et al.. (1985). DNA-mediated transfer of a human DNA repair gene that controls sister chromatid exchange.. Molecular and Cellular Biology. 5(4). 881–884. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact